Literature DB >> 28371394

Principles and approach to developing mammalian cell culture media for high cell density perfusion process leveraging established fed-batch media.

Henry Lin1, Robert Woodrow Leighty1, Scott Godfrey2, Samantha Boran Wang2.   

Abstract

Perfusion medium was successfully developed based on our fed-batch platform basal and feed media. A systematic development approach was undertaken by first optimizing the ratios of fed-batch basal and feed media followed by targeted removal of unnecessary and redundant components. With this reduction in components, the medium could then be further concentrated by 2× to increase medium depth. The medium osmolality was also optimized where we found ∼360 mOsm/kg was desirable resulting in a residual culture osmolality of ∼300 mOsm/kg for our cell lines. Further building on this, the amino acids Q, E, N, and D were rebalanced to reduce lactate and ammonium levels, and increase the cell-specific productivity without compromising on cell viability while leaving viable cell density largely unaffected. Further modifications were also made by increasing certain important vitamin and lipid concentrations, while eliminating other unnecessary vitamins. Overall, an effective perfusion medium was developed with all components remaining in the formulation understood to be important and their concentrations increased to improve medium depth. The critical cell-specific perfusion rate using this medium was then established for a cell line of interest to be 0.075 nL/cell-day yielding 1.2 g/L-day at steady state. This perfusion process was then successfully scaled up to a 100 L single-use bioreactor with an ATF6 demonstrating similar performance as a 2 L bioreactor with an ATF2. Large volume handling challenges in our fed-batch facility were overcome by developing a liquid medium version of the powder medium product contained in custom totes for plug-and-play use with the bioreactor.
© 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:891-901, 2017. © 2017 American Institute of Chemical Engineers.

Entities:  

Keywords:  Chinese hamster ovary cell; cell culture medium development; continuous processing; perfusion process; process intensification

Mesh:

Substances:

Year:  2017        PMID: 28371394     DOI: 10.1002/btpr.2472

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  10 in total

Review 1.  Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

2.  Engineering death resistance in CHO cells for improved perfusion culture.

Authors:  Michael A MacDonald; Matthias Nöbel; Verónica S Martínez; Kym Baker; Evan Shave; Peter P Gray; Stephen Mahler; Trent Munro; Lars K Nielsen; Esteban Marcellin
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

3.  Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature.

Authors:  Bárbara Fernandes; Ricardo Correia; Paula M Alves; António Roldão
Journal:  Front Bioeng Biotechnol       Date:  2022-06-29

4.  Development of a perfusion process for serum-free adenovirus vector herpes zoster vaccine production.

Authors:  Yang Sun; Lingling Huang; Jianqi Nie; Kai Feng; Yupeng Liu; Zhonghu Bai
Journal:  AMB Express       Date:  2022-05-14       Impact factor: 4.126

5.  Rapid development of clone-specific, high-performing perfusion media from established feed supplements.

Authors:  Patrick Mayrhofer; David Reinhart; Andreas Castan; Renate Kunert
Journal:  Biotechnol Prog       Date:  2019-11-11

Review 6.  Developments and opportunities in continuous biopharmaceutical manufacturing.

Authors:  Ohnmar Khanal; Abraham M Lenhoff
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 7.  Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects.

Authors:  Zhongbiao Fang; Jingting Lyu; Jianhua Li; Chaonan Li; Yuxuan Zhang; Yikai Guo; Ying Wang; Yanjun Zhang; Keda Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09

8.  Violacein improves recombinant IgG production by controlling the cell cycle of Chinese hamster ovary cells.

Authors:  Masahide Kido; Hideaki Idogaki; Kouji Nishikawa; Takeshi Omasa
Journal:  Cytotechnology       Date:  2020-11-23       Impact factor: 2.040

9.  Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology.

Authors:  Lisa Stepper; Florian Alois Filser; Simon Fischer; Jochen Schaub; Ingo Gorr; Raphael Voges
Journal:  Bioprocess Biosyst Eng       Date:  2020-04-07       Impact factor: 3.210

10.  Media on-demand: Continuous reconstitution of a chemically defined media directly from solids.

Authors:  Daniel Komuczki; Gregory Dutra; Christoph Gstöttner; Elena Dominguez-Vega; Alois Jungbauer; Peter Satzer
Journal:  Biotechnol Bioeng       Date:  2021-03-25       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.